Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LUCENTIS safely and effectively. See full prescribing information for LUCENTIS. LUCENTIS® (ranibizumab injection) for intravitreal injection Initial U.S. Approval: 2006
Medication labelWhy this: Advisory · dailymed-prescription
LUCENTIS is indicated for the treatment of patients with:
- generic_name
- ranibizumab
- product_names
- RANIBIZUMAB
- ndc
- 50242-080, 50242-082, 50242-080-03, 50242-080-88, 50242-082-88, 50242-082-03
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en